New York – October 13, 2026 -- Fesarius Therapeutics will present its DermiSphereTM hDRT dermal regeneration template at Plastic Surgery The Meeting (PSTM) 2026, October 15–18 at the George R. Brown Convention Center in Houston, Texas. The company will also appear at an event hosted by ASPS Ventures, the medtech venture fund.
Fesarius schedules a one-hour scientific symposium on October 17
The session, "From Benchtop to Bedside - Advancing Dermal Regeneration with Hydrogel Technology," runs 3:30–4:30 p.m. CDT in Innovation Theater B, Exhibit Hall DE. It will cover the science and clinical application of DermiSphereTM hDRT, including its dual-density microarchitecture, recently published clinical data and surgeon experience across complex wound and reconstructive applications.
Jason Spector, MD, will speak and moderate. Spector is Founder and Chief Medical Officer of Fesarius Therapeutics and Chief of the Division of Plastic & Reconstructive Surgery at Weill Cornell Medicine. Brendan MacKay, MD, will also speak. He is Associate Professor of Orthopedic Surgery and UMC Director of Hand and Microvascular Surgery at Texas Tech University Health Sciences Center.
CEO Tom Roueche joins an ASPS Ventures panel the same evening
Fesarius President and CEO Tom Roueche will take part in the ASPS Ventures Expert Panel & Happy Hour, "Connecting Plastic Surgery, Innovation and Investment." The event runs 6:30–8:00 p.m. CDT in the Ballroom of Americas C at the Hilton Hotel, Houston. ASPS Ventures describes itself as a medtech venture fund that brings together plastic surgeons, innovation and investment to advance technologies addressing unmet clinical needs.
DermiSphere hDRT is billed as the first dual-density collagen hydrogel template
Fesarius calls DermiSphereTM hDRT the first and only dual-density collagen hydrogel dermal regeneration template. The scaffold is designed to support tissue integration, rapid vascularization and new tissue formation. Fesarius describes itself as a commercial-stage company. Its team will be at booth #1920 throughout the meeting.